Sara Jenkins – ADC Commercial Manager

Education

• University of Liverpool, 1995, PhD, Synthetic Organic Chemistry

Publications

• Method of synthesising ADC’s using photo-cleavable linkers on solid support: Patent no WO 2016005744 A1 2014

• Preparation of dihydroartemisinin derivatives as antimalarial and anticancer agents; Patent no WO2003048168 2003

• Preparation of dihydroartemisinin derivatives as antimalarial and antitumour agents; Patent no WO2003048167 2003

• A Highly Acid Labile Silicon Linker for Solid Phase Synthesis 1998

Sterling Resources

• Linker payloads at Sterling June 2026

  Explore Sterling’s specialised high‑potency facilities and end‑to‑end capabilities for designing, developing, and manufacturing complex linker payloads, from rapid proof‑of‑concept synthesis to fully contained cGMP production.

• Overcoming purification hurdles for ADC linker payloads June 2025

  Understand the key purification challenges in ADC linker payload synthesis and learn how specialised chromatographic and solvent‑removal strategies help achieve stability, purity, and efficient downstream conjugation.

• Antibody drug conjugates (ADCs) at Sterling April 2022

  Explore Sterling’s integrated ADC capabilities, from high‑potency development and complex linker payloads to fully contained cGMP manufacturing that supports efficient, scalable antibody‑drug conjugate programmes.